ESCO TECHNOLOGIES INC - Quarter Report: 2017 March (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(MARK ONE)
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2017 |
OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ______ TO ______ |
COMMISSION FILE NUMBER 1-10596
ESCO TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
MISSOURI | 43-1554045 |
(State or other jurisdiction of | (I.R.S. Employer |
incorporation or organization) | Identification No.) |
9900A CLAYTON ROAD | |
ST. LOUIS, MISSOURI | 63124-1186 |
(Address of principal executive offices) | (Zip Code) |
(314) 213-7200
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.
Yes x No ¨
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant
to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit and post such files).
Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer x | Accelerated filer ¨ |
Non-accelerated filer ¨ (Do not check if a smaller reporting company) | Smaller reporting company ¨ |
Emerging growth company ¨ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class | Shares outstanding at May 1, 2017 | |
Common stock, $.01 par value per share | 25,830,502 |
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars in thousands, except per share amounts)
Three Months Ended March 31, | ||||||||
2017 | 2016 | |||||||
Net sales | $ | 161,178 | 138,930 | |||||
Costs and expenses: | ||||||||
Cost of sales | 105,379 | 88,118 | ||||||
Selling, general and administrative expenses | 34,889 | 32,529 | ||||||
Amortization of intangible assets | 3,814 | 2,895 | ||||||
Interest expense, net | 855 | 368 | ||||||
Other (income) expenses, net | (578 | ) | 1,405 | |||||
Total costs and expenses | 144,359 | 125,315 | ||||||
Earnings before income taxes | 16,819 | 13,615 | ||||||
Income tax expense | 5,662 | 5,005 | ||||||
Net earnings | $ | 11,157 | 8,610 | |||||
Earnings per share: | ||||||||
Basic - Net earnings | $ | 0.43 | 0.33 | |||||
Diluted - Net earnings | $ | 0.43 | 0.33 |
See accompanying notes to consolidated financial statements.
2 |
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars in thousands, except per share amounts)
Six Months Ended March 31, | ||||||||
2017 | 2016 | |||||||
Net sales | $ | 307,546 | 271,763 | |||||
Costs and expenses: | ||||||||
Cost of sales | 198,293 | 168,167 | ||||||
Selling, general and administrative expenses | 68,651 | 65,820 | ||||||
Amortization of intangible assets | 7,463 | 5,589 | ||||||
Interest expense, net | 1,539 | 597 | ||||||
Other (income) expenses, net | (1,344 | ) | 5,007 | |||||
Total costs and expenses | 274,602 | 245,180 | ||||||
Earnings before income taxes | 32,944 | 26,583 | ||||||
Income tax expense | 11,060 | 9,144 | ||||||
Net earnings | $ | 21,884 | 17,439 | |||||
Earnings per share: | ||||||||
Basic - Net earnings | $ | 0.85 | 0.68 | |||||
Diluted - Net earnings | $ | 0.84 | 0.67 |
See accompanying notes to consolidated financial statements.
3 |
ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
(Dollars in thousands)
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Net earnings | $ | 11,157 | 8,610 | 21,884 | 17,439 | |||||||||||
Other comprehensive income (loss), net of tax: | ||||||||||||||||
Foreign currency translation adjustments | 2,548 | 1,338 | (1,815 | ) | 200 | |||||||||||
Net unrealized gain (loss) on derivative instruments | 29 | 18 | (103 | ) | 82 | |||||||||||
Total other comprehensive income (loss), net of tax | 2,577 | 1,356 | (1,918 | ) | 282 | |||||||||||
Comprehensive income | $ | 13,734 | 9,966 | 19,966 | 17,721 |
See accompanying notes to consolidated financial statements.
4 |
ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in thousands)
March 31, 2017 | September 30, 2016 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 53,500 | 53,825 | |||||
Accounts receivable, net | 119,674 | 121,486 | ||||||
Costs and estimated earnings on long-term contracts, less progress billings of $39,897 and $31,129, respectively | 36,261 | 28,746 | ||||||
Inventories | 117,509 | 105,542 | ||||||
Other current assets | 16,600 | 13,884 | ||||||
Total current assets | 343,544 | 323,483 | ||||||
Property, plant and equipment, net of accumulated depreciation of $92,736 and $84,454, respectively | 116,945 | 92,405 | ||||||
Intangible assets, net of accumulated amortization of $64,380 and $56,955, respectively | 265,273 | 231,759 | ||||||
Goodwill | 353,984 | 323,616 | ||||||
Other assets | 5,379 | 7,108 | ||||||
Total assets | $ | 1,085,125 | 978,371 | |||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Current maturities of long-term debt | $ | 20,000 | 20,000 | |||||
Accounts payable | 42,442 | 42,074 | ||||||
Advance payments on long-term contracts, less costs incurred of $41,754 and $35,266, respectively | 22,444 | 16,187 | ||||||
Accrued salaries | 22,285 | 28,769 | ||||||
Current portion of deferred revenue | 31,090 | 27,212 | ||||||
Accrued other expenses | 24,080 | 23,834 | ||||||
Total current liabilities | 162,341 | 158,076 | ||||||
Pension obligations | 40,189 | 39,842 | ||||||
Deferred tax liabilities | 84,134 | 69,562 | ||||||
Other liabilities | 14,826 | 5,782 | ||||||
Long-term debt | 150,000 | 90,000 | ||||||
Total liabilities | 451,490 | 363,262 | ||||||
Shareholders’ equity: | ||||||||
Preferred stock, par value $.01 per share, authorized 10,000,000 shares | – | – | ||||||
Common stock, par value $.01 per share, authorized 50,000,000 shares, issued 30,364,183 and 30,364,183 shares, respectively | 304 | 304 | ||||||
Additional paid-in capital | 293,169 | 290,588 | ||||||
Retained earnings | 489,033 | 471,272 | ||||||
Accumulated other comprehensive loss, net of tax | (41,201 | ) | (39,283 | ) | ||||
741,305 | 722,881 | |||||||
Less treasury stock, at cost: 4,641,022 and 4,647,322 common shares, respectively | (107,670 | ) | (107,772 | ) | ||||
Total shareholders’ equity | 633,635 | 615,109 | ||||||
Total liabilities and shareholders’ equity | $ | 1,085,125 | 978,371 |
See accompanying notes to consolidated financial statements.
5 |
ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in thousands)
Six Months Ended March 31, | ||||||||
2017 | 2016 | |||||||
Cash flows from operating activities: | ||||||||
Net earnings | $ | 21,884 | 17,439 | |||||
Adjustments to reconcile net earnings to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 14,688 | 11,238 | ||||||
Stock compensation expense | 2,870 | 2,689 | ||||||
Changes in assets and liabilities | (4,972 | ) | (26,494 | ) | ||||
Effect of deferred taxes | (1,645 | ) | 1,646 | |||||
Change in deferred revenue and costs, net | 3,948 | 1,992 | ||||||
Pension contributions | (360 | ) | - | |||||
Other | 242 | 569 | ||||||
Net cash provided by operating activities | 36,655 | 9,079 | ||||||
Cash flows from investing activities: | ||||||||
Acquisition of businesses, net of cash acquired | (75,000 | ) | (41,308 | ) | ||||
Additions to capitalized software | (3,445 | ) | (3,716 | ) | ||||
Capital expenditures | (15,435 | ) | (5,284 | ) | ||||
Proceeds from life insurance | 2,307 | - | ||||||
Net cash used by investing activities | (91,573 | ) | (50,308 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from long-term debt | 103,000 | 76,890 | ||||||
Principal payments on long-term debt | (43,000 | ) | (28,000 | ) | ||||
Dividends paid | (4,115 | ) | (4,131 | ) | ||||
Purchases of common stock into treasury | - | (3,088 | ) | |||||
Debt issuance costs | - | (1,037 | ) | |||||
Other | (112 | ) | 89 | |||||
Net cash provided by financing activities | 55,773 | 40,723 | ||||||
Effect of exchange rate changes on cash and cash equivalents | (1,180 | ) | (146 | ) | ||||
Net decrease in cash and cash equivalents | (325 | ) | (652 | ) | ||||
Cash and cash equivalents, beginning of period | 53,825 | 39,411 | ||||||
Cash and cash equivalents, end of period | $ | 53,500 | 38,759 |
See accompanying notes to consolidated financial statements.
6 |
ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. | BASIS OF PRESENTATION |
The accompanying consolidated financial statements, in the opinion of management, include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the results for the interim periods presented. The consolidated financial statements are presented in accordance with the requirements of Form 10-Q and consequently do not include all the disclosures required for annual financial statements by accounting principles generally accepted in the United States of America (GAAP). For further information, refer to the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2016.
The Company’s results for the three and six-month periods ended March 31, 2017 are not necessarily indicative of the results for the entire 2017 fiscal year. References to the second quarters of 2017 and 2016 represent the fiscal quarters ended March 31, 2017 and 2016, respectively.
The preparation of financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities. Actual results could differ from those estimates.
2. | ACQUISITION |
On November 7, 2016, the Company acquired aerospace suppliers Mayday Manufacturing Co. and its affiliate, Hi-Tech Metals, Inc. (collectively referred to as Mayday), which share a 130,000 square foot facility in Denton, Texas, for a purchase price of $75 million in cash. Mayday Manufacturing Co. is a leading manufacturer of mission-critical bushings, pins, sleeves and precision-tolerance machined components for landing gear, rotor heads, engine mounts, flight controls, and actuation systems for the aerospace and defense industry. Hi-Tech Metals, Inc. is a full-service metal processor offering aerospace OEM’s, Tier 1 suppliers, a large portfolio of processing services including anodizing, cadmium and zinc-nickel plating, organic coatings, non-destructive testing, and heat treatment. Mayday has annual sales of approximately $40 million. Since the date of acquisition the consolidated operating results for Mayday have been included in the Company’s Filtration segment. Based on the preliminary purchase price allocation, the Company recorded approximately $7.4 million of accounts receivable, $11.0 million of inventory, $16.6 million of property, plant and equipment (including a capital lease), $9.5 million of lease liability, $15.7 million of deferred tax liabilities, $30.1 million of goodwill (non-deductible for tax purposes), $4.8 million of trade names and $32.8 million of amortizable identifiable intangible assets consisting primarily of customer relationships with a weighted-average life of approximately 20 years.
3. | EARNINGS PER SHARE (EPS) |
Basic EPS is calculated using the weighted average number of common shares outstanding during the period. Diluted EPS is calculated using the weighted average number of common shares outstanding during the period plus shares issuable upon the assumed exercise of dilutive common share options and vesting of performance-accelerated restricted shares (restricted shares) by using the treasury stock method. The number of shares used in the calculation of earnings per share for each period presented is as follows (in thousands):
7 |
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Weighted Average Shares Outstanding - Basic | 25,723 | 25,786 | 25,721 | 25,801 | ||||||||||||
Dilutive Options and Restricted Shares | 188 | 145 | 224 | 185 | ||||||||||||
Adjusted Shares - Diluted | 25,911 | 25,931 | 25,945 | 25,986 |
4. | SHARE-BASED COMPENSATION |
The Company provides compensation benefits to certain key employees under several share-based plans providing for performance-accelerated restricted shares (restricted shares), and to non-employee directors under a non-employee directors compensation plan.
Performance-Accelerated Restricted Share Awards
Compensation expense related to the restricted share awards was $1.2 million and $2.4 million for the three and six-month periods ended March 31, 2017, respectively, and $1.2 million and $2.3 million for the corresponding periods of 2016. There were 324,225 non-vested shares outstanding as of March 31, 2017.
Non-Employee Directors Plan
Compensation expense related to the non-employee director grants was $0.2 million and $0.5 million for the three and six-month periods ended March 31, 2017, respectively, and $0.2 million and $0.4 million for the corresponding periods of 2016.
The total share-based compensation cost that has been recognized in the results of operations and included within selling, general and administrative expenses (SG&A) was $1.4 million and $2.9 million for the three-and six-month periods ended March 31, 2017, respectively, and $1.4 million and $2.7 million for the three and six-month periods ended March 31, 2016. The total income tax benefit recognized in results of operations for share-based compensation arrangements was $0.5 million and $1.1 million for the three and six-month periods ended March 31, 2017, respectively, and $0.5 million and $1.0 million for the three and six-month periods ended March 31, 2016, respectively. As of March 31, 2017, there was $7.6 million of total unrecognized compensation cost related to share-based compensation arrangements. That cost is expected to be recognized over a remaining weighted-average period of 1.9 years.
5. | INVENTORIES |
Inventories consist of the following:
(In thousands) | March 31, 2017 | September 30, 2016 | ||||||
Finished goods | $ | 23,718 | 19,451 | |||||
Work in process | 44,019 | 37,922 | ||||||
Raw materials | 49,772 | 48,169 | ||||||
Total inventories | $ | 117,509 | 105,542 |
8 |
6. | GOODWILL AND OTHER INTANGIBLE ASSETS |
Included on the Company’s Consolidated Balance Sheets at March 31, 2017 and September 30, 2016 are the following intangible assets gross carrying amounts and accumulated amortization:
(Dollars in thousands) | March 31, 2017 | September 30, 2016 | ||||||
Goodwill | $ | 353,984 | 323,616 | |||||
Intangible assets with determinable lives: | ||||||||
Patents | ||||||||
Gross carrying amount | $ | 931 | 917 | |||||
Less: accumulated amortization | 751 | 726 | ||||||
Net | $ | 180 | 191 | |||||
Capitalized software | ||||||||
Gross carrying amount | $ | 57,451 | 54,003 | |||||
Less: accumulated amortization | 30,301 | 26,737 | ||||||
Net | $ | 27,150 | 27,266 | |||||
Customer relationships | ||||||||
Gross carrying amount | $ | 144,287 | 111,887 | |||||
Less: accumulated amortization | 32,244 | 28,633 | ||||||
Net | $ | 112,043 | 83,254 | |||||
Other | ||||||||
Gross carrying amount | $ | 3,178 | 2,777 | |||||
Less: accumulated amortization | 1,084 | 859 | ||||||
Net | $ | 2,094 | 1,918 | |||||
Intangible assets with indefinite lives: | ||||||||
Trade names | $ | 123,807 | 119,128 |
The changes in the carrying amount of goodwill attributable to each business segment for the six months ended March 31, 2017 is as follows:
(Dollars in millions) | USG | Test | Filtration | Packaging | Total | |||||||||||||||
Balance as of September 30, 2016 | 226.2 | 34.1 | 43.9 | 19.4 | 323.6 | |||||||||||||||
Acquisition activity | - | - | 30.7 | 30.7 | ||||||||||||||||
Foreign currency translation | - | - | - | (0.3 | ) | (0.3 | ) | |||||||||||||
Balance as of March 31, 2017 | $ | 226.2 | 34.1 | 74.6 | 19.1 | 354.0 |
7. | BUSINESS SEGMENT INFORMATION |
The Company is organized based on the products and services that it offers, and classifies its business operations in four segments for financial reporting purposes: Filtration/Fluid Flow (Filtration), RF Shielding and Test (Test), Utility Solutions Group (USG) and Technical Packaging. The Filtration segment’s operations consist of PTI Technologies Inc. (PTI), VACCO Industries (VACCO), Crissair, Inc. (Crissair), Westland Technologies Inc. (Westland), Mayday and its affiliate Hi-Tech. The companies within this segment primarily design and manufacture specialty filtration products, including hydraulic filter elements used in commercial aerospace applications, unique filter mechanisms used in micro-propulsion devices for satellites and custom designed filters for manned and unmanned aircraft; manufacture elastomeric-based signature reduction solutions for the U.S. Navy; and manufacture landing gear components for the aerospace and defense industry. The Test segment’s operations consist primarily of ETS-Lindgren Inc. (ETS-Lindgren). ETS-Lindgren is an industry leader in providing its customers with the ability to identify, measure and contain magnetic, electromagnetic and acoustic energy. The USG segment’s operations consist primarily of Doble Engineering Company (Doble). Doble provides high-end, intelligent diagnostic test solutions for the electric power delivery industry and is a leading supplier of partial discharge testing instruments used to assess the integrity of high voltage power delivery equipment. The Technical Packaging segment’s operations consist of Thermoform Engineered Quality LLC (TEQ) and Plastique Limited and Plastique Sp. zoo (together, Plastique). The companies within this segment provide innovative solutions to the medical and commercial markets for thermoformed packages and specialty products using a wide variety of thin gauge plastics and pulp.
9 |
Management evaluates and measures the performance of its reportable segments based on “Net Sales” and “EBIT”, which are detailed in the table below. EBIT is defined as earnings before interest and taxes.
(In thousands) | Three Months Ended March 31, | Six Months Ended March 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
NET SALES | ||||||||||||||||
Filtration | $ | 68,906 | 49,045 | 127,690 | 91,361 | |||||||||||
Test | 38,367 | 40,601 | 72,194 | 83,374 | ||||||||||||
USG | 32,671 | 30,014 | 68,228 | 64,537 | ||||||||||||
Technical Packaging | 21,234 | 19,270 | 39,434 | 32,491 | ||||||||||||
Consolidated totals | $ | 161,178 | 138,930 | 307,546 | 271,763 | |||||||||||
EBIT | ||||||||||||||||
Filtration | $ | 11,625 | 9,064 | 22,351 | 17,348 | |||||||||||
Test | 3,766 | 2,505 | 6,191 | 4,843 | ||||||||||||
USG | 7,434 | 7,208 | 17,108 | 15,457 | ||||||||||||
Technical Packaging | 2,196 | 2,747 | 3,227 | 4,560 | ||||||||||||
Corporate (loss) | (7,347 | ) | (7,541 | ) | (14,394 | ) | (15,028 | ) | ||||||||
Consolidated EBIT | 17,674 | 13,983 | 34,483 | 27,180 | ||||||||||||
Less: Interest expense | (855 | ) | (368 | ) | (1,539 | ) | (597 | ) | ||||||||
Earnings before income taxes | $ | 16,819 | 13,615 | 32,944 | 26,583 |
Non-GAAP Financial Measures
The financial measure “EBIT” is presented in the above table and elsewhere in this Report. EBIT on a consolidated basis is a non-GAAP financial measure. Management believes that EBIT is useful in assessing the operational profitability of the Company’s business segments because it excludes interest and taxes, which are generally accounted for across the entire Company on a consolidated basis. EBIT is also one of the measures used by management in determining resource allocations within the Company as well as incentive compensation. A reconciliation of EBIT to net earnings is set forth in Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations – EBIT.
The Company believes that the presentation of EBIT provides important supplemental information to investors to facilitate comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results. However, the Company’s non-GAAP financial measures may not be comparable to other companies’ non-GAAP financial performance measures. Furthermore, the use of non-GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP.
10 |
8. | DEBT |
The Company’s debt is summarized as follows:
(In thousands) | March 31, 2017 | September 30, 2016 | ||||||
Total borrowings | $ | 170,000 | 110,000 | |||||
Short-term borrowings and current portion of long-term debt | (20,000 | ) | (20,000 | ) | ||||
Total long-term debt, less current portion | $ | 150,000 | 90,000 |
The Company’s existing credit facility maturity date is December 21, 2020. The credit facility includes a $450 million revolving line of credit as well as provisions allowing for the increase of the credit facility commitment amount by an additional $250 million, if necessary, with the consent of the lenders. The bank syndication supporting the facility is comprised of a diverse group of nine banks led by JPMorgan Chase Bank, N.A., as Administrative Agent.
At March 31, 2017, the Company had approximately $276 million available to borrow under the Credit Facility, and a $250 million increase option, in addition to $53.5 million cash on hand. At March 31, 2017, the Company had $170 million of outstanding borrowings under the credit facility in addition to outstanding letters of credit of $4.6 million. The Company classified $20.0 million as the current portion of long-term debt as of March 31, 2017, as the Company intends to repay this amount within the next twelve month period; however, the Company has no contractual obligation to repay such amount during the next twelve month period.
The Credit Facility requires, as determined by certain financial ratios, a facility fee ranging from 12.5 to 27.5 basis points per year on the unused portion. The terms of the facility provide that interest on borrowings may be calculated at a spread over the London Interbank Offered Rate (LIBOR) or based on the prime rate, at the Company’s election. The facility is secured by the unlimited guaranty of the Company’s material domestic subsidiaries and a 65% pledge of the material foreign subsidiaries’ share equity. The financial covenants of the Credit Facility include a leverage ratio and an interest coverage ratio. The weighted average interest rates were 1.89% and 1.76% for the three and six-month periods ending March 31, 2017, respectively, and 1.76% and 1.61% for the corresponding periods of 2016. At March 31, 2017, the Company was in compliance with all debt covenants.
9. | INCOME TAX EXPENSE |
The second quarter 2017 effective income tax rate was 33.7% compared to 36.8% in the second quarter of 2016. The effective income tax rate for the first six months of 2017 was 33.6% compared to 34.4% for the first six months of 2016. The income tax expense in the second quarter and first six months of 2017 was unfavorably impacted by a decrease in the foreign tax rate benefit of 0.8% and 1.4%, respectively.
The income tax expense in the second quarter and first six months of 2016 was unfavorably impacted by a U.K. foreign valuation allowance that increased the second quarter and year-to-date effective tax rate by 4.8% and 2.5%, respectively. The income tax expense in the first six months of 2016 was favorably impacted by the extension of the research credit as a result of The Protecting Americans from Tax Hikes Act reducing the year-to-date effective tax rate by 3.0%. The income tax expense in the first six months of 2016 was unfavorably impacted by losses in foreign jurisdictions for which no tax benefit was recorded, increasing the year-to-date effective tax rate by 2.8%.
The Company estimates the fiscal 2017 effective tax rate will be approximately 34%. During the three-month period ended March 31, 2017, there were no material changes in the unrecognized tax benefits. The Company does not anticipate a material change in the amount of unrecognized tax benefits in the next twelve months.
10. | SHAREHOLDERS’ EQUITY |
The change in shareholders’ equity for the first six months of 2017 is shown below (in thousands):
Balance at September 30, 2016 | $ | 615,109 | ||
Net earnings | 21,884 | |||
Other comprehensive loss | (1,918 | ) | ||
Cash dividends | (4,123 | ) | ||
Stock compensation plans | 2,683 | |||
Balance at March 31, 2017 | $ | 633,635 |
11 |
11. | RETIREMENT PLANS |
A summary of net periodic benefit expense for the Company’s defined benefit plans for the three and six-month periods ended March 31, 2017 and 2016 is shown in the following table. Net periodic benefit cost for each period presented is comprised of the following:
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
(In thousands) | 2017 | 2016 | 2017 | 2016 | ||||||||||||
Defined benefit plans | ||||||||||||||||
Interest cost | $ | 737 | 963 | 1,702 | 1,925 | |||||||||||
Expected return on assets | (942 | ) | (1,093 | ) | (2,036 | ) | (2,187 | ) | ||||||||
Amortization of: | ||||||||||||||||
Prior service cost | - | 3 | 3 | 7 | ||||||||||||
Actuarial loss | 683 | 486 | 1,188 | 972 | ||||||||||||
Net periodic benefit cost | $ | 478 | 359 | 857 | 717 |
12. | DERIVATIVE FINANCIAL INSTRUMENTS |
Market risks relating to the Company’s operations result primarily from changes in interest rates and changes in foreign currency exchange rates. The Company is exposed to market risk related to changes in interest rates and selectively uses derivative financial instruments, including forward contracts and swaps, to manage these risks. During 2016, the Company entered into several forward contracts to purchase pounds sterling (GBP) to hedge two deferred payments due in connection with the acquisition of Plastique. The Company expects hedging gains or losses to be essentially offset by losses or gains on the related underlying exposures. All derivative instruments are reported in accrued expenses on the balance sheet at fair value. The derivative instruments are designated as cash flow hedges and the gain or loss on the derivative is deferred in accumulated other comprehensive income until recognized in earnings with the underlying hedged item.
The following is a summary of the notional transaction amounts and fair values for the Company’s outstanding derivative financial instruments by risk category and instrument type as of March 31, 2017:
(In thousands) | Notional amount (GBP) | Fair Value (US$) | ||||||
Forward contracts | 1,859 | (318 | ) |
13. | FAIR VALUE MEASUREMENTS |
The accounting guidance establishes a three-level hierarchy for disclosure of fair value measurements, based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date, as follows:
· | Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. |
· | Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. |
· | Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement. |
Financial Assets and Liabilities
The Company has estimated the fair value of its financial instruments as of March 31, 2017 and September 30, 2016 using available market information or other appropriate valuation methodologies. The carrying amounts of cash and cash equivalents, receivables, inventories, payables, debt and other current assets and liabilities approximate fair value because of the short maturity of those instruments.
12 |
Fair Value of Financial Instruments
The Company’s forward contracts are classified within Level 2 of the valuation hierarchy in accordance with FASB Accounting Standards Codification (ASC) 825, as presented below as of March 31, 2017:
(In thousands) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Liabilities: | ||||||||||||||||
Forward contracts | $ | - | (318 | ) | $ | - | (318 | ) |
Valuation was based on third party evidence of similarly priced derivative instruments.
Nonfinancial Assets and Liabilities
The Company’s nonfinancial assets such as property, plant and equipment, and other intangible assets are not measured at fair value on a recurring basis; however they are subject to fair value adjustments in certain circumstances, such as when there is evidence that an impairment may exist. No impairments were recorded during the three and six-month periods ended March 31, 2017.
14. | SUBSEQUENT EVENT |
On May 8, 2017, the Company acquired NRG Systems, Inc. (NRG), doing business as Renewable NRG Systems, located in Hinesburg, Vermont. NRG, founded in 1982, is the global market leader in the design and manufacture of decision support tools for the renewable energy industry, primarily wind. NRG has annualized sales of approximately $45 million and will be included in the Company’s Utilities Solution Group (USG) segment.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
RESULTS OF OPERATIONS
References to the second quarters of 2017 and 2016 represent the three-month periods ended March 31, 2017 and 2016, respectively.
OVERVIEW
In the second quarter of 2017, sales, net earnings and diluted earnings per share were $161.2 million, $11.2 million and $0.43 per share, respectively, compared to $138.9 million, $8.6 million and $0.33 per share, respectively, in the second quarter of 2016. In the first six months of 2017, sales, net earnings and diluted earnings per share were $307.5 million, $21.9 million and $0.84, respectively, compared to $271.8 million, $17.4 million and $0.67 per share, respectively, in the first six months of 2016.
NET SALES
Net sales increased $22.2 million, or 16.0%, to $161.2 million in the second quarter of 2017 from $138.9 million in the second quarter of 2016. Net sales increased $35.8 million, or 13.2%, to $307.5 million in the first six months of 2017 from $271.8 million in the first six months of 2016. The increase in net sales in the second quarter of 2017 as compared to the second quarter of 2016 was due to a $19.9 million increase in the Filtration segment, a $2.7 million increase in the USG segment and a $2.0 million increase in the Technical Packaging segment, partially offset by a $2.2 million decrease in the Test segment. The increase in net sales in the first six months of 2017 as compared to the corresponding prior year period was due to a to a $36.3 million increase in the Filtration segment, a $6.9 million increase in the Technical Packaging segment and a $3.7 million increase in the USG segment, partially offset by a $11.2 million decrease in the Test segment.
-Filtration
In the second quarter of 2017, net sales of $68.9 million were $19.9 million, or 40.5%, higher than the $49.0 million in the second quarter of 2016. Net sales increased $36.3 million, or 39.8%, to $127.7 million in the first six months of 2017 from $91.4 million in the first six months of 2016. The sales increase in the second quarter of 2017 compared to the second quarter of 2016 was mainly due to the sales contributions from the Company’s recent acquisitions of Westland ($5.4 million) and Mayday ($10.3 million); and a $3.4 million increase in net sales at VACCO due to higher shipments of its space and defense products. The sales increase in the first six months of 2017 compared to the first six months of 2016 was primarily due to the sales contributions from the Company’s recent acquisitions of Westland ($12.1 million) and Mayday ($16.6 million); and a $6.7 million increase in net sales at VACCO due to higher shipments of its space and defense products.
13 |
-Test
In the second quarter of 2017, net sales of $38.4 million were $2.2 million, or 5.5%, lower than the $40.6 million recorded in the second quarter of 2016. Net sales decreased $11.2 million, or 13.4%, to $72.2 million in the first six months of 2017 from $83.4 million in the first six months of 2016. The decrease in the second quarter of 2017 compared to the second quarter of 2016 was primarily due to lower sales from the segment’s European operations. The decrease in the first six months of 2017 compared to the first six months of 2016 was mainly due to a decrease in net sales from the segment’s U.S. and European operations mainly due to the timing of projects and lower sales volumes of domestic shielding products.
-Utility Solutions Group (USG)
Net sales increased $2.7 million, or 8.9%, to $32.7 million in the second quarter of 2017 from $30.0 million in the second quarter of 2016. Net sales increased $3.7 million, or 5.7%, to $68.2 million in the first six months of 2017 from $64.5 million in the first six months of 2016. The increase in the second quarter and first six months of 2017 compared to the corresponding periods of 2016 was mainly driven by the additional contribution from new products and software solutions at Doble.
-Technical Packaging
In the second quarter of 2017, net sales of $21.2 million were $1.9 million, or 10.2%, higher than the $19.3 million in the second quarter of 2016. Net sales increased $6.9 million, or 21.4%, to $39.4 million in the first six months of 2017 from $32.5 million in the first six months of 2016. The increase in the second quarter of 2017 compared to the second quarter of 2016 was due to the sales contribution from Plastique which was acquired in January 2016. The increase in the first six months of 2017 compared to the first six months of 2016 was mainly due to the $9.0 million sales contribution from Plastique partially offset by a $2.1 million decrease in net sales from TEQ due to lower shipments to medical customers.
ORDERS AND BACKLOG
Backlog was $374.6 million at March 31, 2017 compared with $332.4 million at September 30, 2016. The Company received new orders totaling $166.9 million in the second quarter of 2017 compared to $129.9 million in the second quarter of 2016. Of the new orders received in the second quarter of 2017, $62.0 million related to Filtration products, $44.2 million related to Test products, $33.0 million related to USG products, and $27.6 million related to Technical Packaging products. Of the new orders received in the second quarter of 2016, $42.2 million related to Filtration products, $34.7 million related to Test products, $29.0 million related to USG products, and $24.0 million related to Technical Packaging products
The Company received new orders totaling $349.8 million in the first six months of 2017 compared to $272.6 million in the first six months of 2016. Of the new orders received in the first six months of 2017, $129.5 million related to Filtration products, $100.2 million related to Test products, $72.6 million related to USG products, and $47.4 million related to Technical Packaging products. Of the new orders received in the first six months of 2016, $99.0 million related to Filtration products, $73.6 million related to Test products, $60.3 million related to USG products, and $39.7 million related to Technical Packaging products.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
Selling, general and administrative (SG&A) expenses for the second quarter of 2017 were $34.9 million (21.6% of net sales), compared with $32.5 million (23.4% of net sales) for the second quarter of 2016. For the first six months of 2017, SG&A expenses were $68.7 million (22.3% of net sales) compared to $65.8 million (24.2% of net sales) for the first six months of 2016. The increase in SG&A in the second quarter and first six months of 2017 compared to the corresponding periods of 2016 was mainly due to an increase in SG&A expenses in the Filtration and Technical Packaging segments due to the Company’s recent acquisitions (Westland, Mayday and Plastique) and additional sales and marketing expenses at Doble partially offset by a decrease in SG&A expenses in the Test segment (as a result of the 2016 restructuring activities), Crissair and Corporate (lower professional fees related to M&A activities).
14 |
AMORTIZATION OF INTANGIBLE ASSETS
Amortization of intangible assets was $3.8 million and $7.5 million for the second quarter and first six months of 2017, respectively, compared to $2.9 million and $5.6 million for the corresponding periods of 2016. Amortization expenses consist of amortization of acquired intangible assets from acquisitions and other identifiable intangible assets (primarily software). The increase in amortization expense in the second quarter and first six months of 2017 compared to the corresponding periods of 2016 was mainly due to an increase in amortization of intangibles related to the Westland, Mayday and Plastique acquisitions.
OTHER (INCOME) EXPENSES, NET
Other income, net, was $0.6 million in the second quarter of 2017 compared to other expenses, net, of $1.4 million in the second quarter of 2016. There were no individually significant items in other (income) expenses, net, in the second quarter of 2017. The principal components in other expenses, net, in the second quarter of 2016 were $1.2 million of restructuring costs related to the Test segment facility consolidation and $0.2 million of costs related to the USG segment restructuring activities. The restructuring costs mainly related to severance and compensation benefits, professional fees and asset impairment charges related to abandoned assets.
Other income, net, was $1.3 million in the first six months of 2017 compared to other expenses, net, of $5.0 million in the first six months of 2016. The principal component in other income, net, in the first six months of 2017 was $0.4 million of income related to death benefit insurance proceeds from a former employee. The principal components in other expenses, net, in the first six months of 2016 were $3.5 million of restructuring costs related to the Test segment and $1.5 million of costs related to the USG segment restructuring activities.
EBIT
The Company evaluates the performance of its operating segments based on EBIT, and provides EBIT on a consolidated basis, which is a non-GAAP financial measure. Please refer to the discussion of non-GAAP financial measures in Note 7 to the Consolidated Financial Statements, above. EBIT was $17.7 million (11.0% of net sales) for the second quarter of 2017 compared to $14.0 million (10.1% of net sales) for the second quarter of 2016. For the first six months of 2017, EBIT was $34.5 million (11.2% of net sales) compared to $27.2 million (10.0% of net sales) for the first six months of 2016.
The following table presents a reconciliation of EBIT to net earnings.
(In thousands) | Three Months Ended March 31, | Six Months Ended March 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Consolidated EBIT | $ | 17,674 | 13,983 | 34,483 | 27,180 | |||||||||||
Less: Interest expense, net | (855 | ) | (368 | ) | (1,539 | ) | (597 | ) | ||||||||
Less: Income tax expense | (5,662 | ) | (5,005 | ) | (11,060 | ) | (9,144 | ) | ||||||||
Net earnings | $ | 11,157 | 8,610 | 21,884 | 17,439 |
-Filtration
EBIT in the second quarter of 2017 was $11.6 million (16.9% of net sales) compared to $9.1 million (18.5% of net sales) in the second quarter of 2016. In the first six months of 2017, EBIT was $22.4 million (17.5% of net sales) compared to $17.3 million (19.0% of net sales) in the first six months of 2016. The increase in EBIT in the second quarter and first six months of 2017 compared to the corresponding prior year periods was mainly due to the EBIT contribution from Westland (September 2, 2016 acquisition) and an increase at PTI and VACCO due to the higher sales volumes. EBIT as a percent of net sales decreased in the second quarter and first six months of 2017 compared to the respective 2016 periods mainly due to the inventory step-up charge at Mayday of $1.0 million and $1.9 million in the second quarter and first six months of 2017, respectively.
-Test
EBIT in the second quarter of 2017 was $3.8 million (9.8% of net sales) compared to $2.5 million (6.2% of net sales) in the second quarter of 2016. In the first six months of 2017, EBIT was $6.2 million (8.6% of net sales) compared to $4.8 million (5.8% of net sales) in the first six months of 2016. EBIT increased in the first six months of 2017 compared to the first six months of 2016 primarily due to the $3.7 million of restructuring charges incurred in the first six months of 2016 related to closing the Test business operating facilities in Germany and England, consisting mainly of employee severance and compensation benefits, professional fees, and asset impairment charges; partially offset by a decrease in EBIT related to the lower sales volumes.
15 |
-Utility Solutions Group
EBIT in the second quarter of 2017 was $7.4 million (22.8% of net sales) compared to $7.2 million (24.0% of net sales) in the second quarter of 2016. In the first six months of 2017, EBIT was $17.1 million (25.1% of net sales) compared to EBIT of $15.5 million (24.0% of net sales) in the first six months of 2016. The increase in EBIT in the second quarter and first six months of 2017 compared to the corresponding periods of 2016 was mainly due to higher sales volumes and additional contribution from new products and software solutions, partially offset by higher expenditures due to the timing of the annual Client Conference.
-Technical Packaging
EBIT in the second quarter of 2017 was $2.2 million (10.3% of net sales) compared to $2.7 million (14.3% of net sales) in the second quarter of 2016. In the first six months of 2017, EBIT was $3.2 million (8.2% of net sales) compared to $4.6 million (14.0% of net sales) in the first six months of 2016. The decrease in EBIT in the second quarter and first six months of 2017 compared to the corresponding periods of 2016 was mainly due to lower sales volumes at TEQ and higher SG&A expense.
-Corporate
Corporate costs included in EBIT were $7.3 million and $14.4 million in the second quarter and first six months of 2017, respectively, compared to $7.5 million and $15.0 million in the corresponding periods of 2016. The decrease in Corporate costs in the second quarter and first six months of 2017 compared to the corresponding periods of 2016 was primarily due to lower professional fees.
INTEREST EXPENSE, NET
Interest expense was $0.9 million and $1.5 million in the second quarter and first six months of 2017, respectively, and $0.4 million and $0.6 million in the corresponding periods of 2016. The increase in interest expense in the second quarter and first six months of 2017 compared to the corresponding periods of 2016 was mainly due to higher outstanding borrowings during the current year as a result of the Company’s recent acquisitions (Westland and Mayday).
INCOME TAX EXPENSE
The second quarter 2017 effective income tax rate was 33.7% compared to 36.8% in the second quarter of 2016. The effective income tax rate for the first six months of 2017 was 33.6% compared to 34.4% for the first six months of 2016. The income tax expense in the second quarter and first six months of 2017 was unfavorably impacted by a decrease in the foreign tax rate benefit of 0.8% and 1.4%, respectively.
The income tax expense in the second quarter and first six months of 2016 was unfavorably impacted by a U.K. foreign valuation allowance that increased the second quarter and year-to-date effective tax rate by 4.8% and 2.5%, respectively. The income tax expense in the first six months of 2016 was favorably impacted by the extension of the research credit as a result of The Protecting Americans from Tax Hikes Act reducing the year-to-date effective tax rate by 3.0%. The income tax expense in the first six months of 2016 was unfavorably impacted by losses in foreign jurisdictions for which no tax benefit was recorded, increasing the year-to-date effective tax rate by 2.8%.
The Company estimates the fiscal 2017 effective tax rate will be approximately 34%. During the three-month period ended March 31, 2017, there were no material changes in the unrecognized tax benefits. The Company does not anticipate a material change in the amount of unrecognized tax benefits in the next twelve months.
The Company’s foreign subsidiaries had accumulated unremitted earnings of $49.8 million and cash of $40.1 million at March 31, 2017. No deferred taxes have been provided on the accumulated unremitted earnings because these funds are not needed to meet the liquidity requirements of the Company’s U.S. operations and it is the Company’s intention to reinvest these earnings indefinitely. In the event these foreign entities’ earnings were distributed, it is estimated that U.S. taxes, net of available foreign tax credits, of approximately $4.8 million would be due, which would correspondingly reduce the Company’s net earnings.
16 |
CAPITAL RESOURCES AND LIQUIDITY
The Company’s overall financial position and liquidity remains strong. Working capital (current assets less current liabilities) increased to $181.2 million at March 31, 2017 from $165.4 million at September 30, 2016. Inventories increased by $12.0 million during this period mainly due to an $11.5 million increase within the Filtration segment primarily related to the acquisition of Mayday in the first quarter of 2017. Costs and estimated earnings in excess of billings on long-term contracts increased $7.5 million in the first six months of 2017 due to VACCO ($5.5 million) and ETS ($2.0 million).
Net cash provided by operating activities was $36.7 million and $9.1 million in the first six months of 2017 and 2016, respectively. The increase in net cash provided by operating activities in the first six months of 2017 as compared to the first six months of 2016 was due to higher net earnings and lower working capital requirements.
Capital expenditures were $15.4 million and $5.3 million in the first six months of 2017 and 2016, respectively. The increase in the first six months of 2017 was mainly due to an increase in machinery and equipment additions at Plastique ($4.1 million) and VACCO ($3.1 million). In addition, the Company incurred expenditures for capitalized software of $3.4 million and $3.7 million in the first six months of 2017 and 2016, respectively.
Credit Facility
At March 31, 2017, the Company had approximately $276 million available to borrow under its bank credit facility, a $250 million increase option, and $53.5 million cash on hand. At March 31, 2017, the Company had $170.0 million of outstanding borrowings under the credit facility in addition to outstanding letters of credit of $4.6 million. Cash flow from operations and borrowings under the Company’s credit facility are expected to meet the Company’s capital requirements and operational needs for the foreseeable future. The Company’s ability to access the additional $250 million increase option of the credit facility is subject to acceptance by participating or other outside banks.
Acquisition
On November 7, 2016, the Company acquired aerospace supplier Mayday, located in Denton, Texas, for a purchase price of $75 million in cash. Since the date of acquisition the consolidated operating results for Mayday have been included in the Company’s Filtration segment.
Dividends
A dividend of $0.08 per share was paid on October 17, 2016 to stockholders of record as of October 3, 2016, totaling $2.1 million. A dividend of $0.08 per share was paid on January 19, 2017 to stockholders of record as of January 4, 2017, totaling $2.1 million. Subsequent to March 31, 2017, a quarterly dividend of $0.08 per share, totaling $2.1 million, was paid on April 18, 2017 to stockholders of record as of April 3, 2017.
Subsequent Event
On May 8, 2017, the Company acquired NRG Systems, Inc. (NRG), doing business as Renewable NRG Systems, located in Hinesburg, Vermont. NRG, founded in 1982, is the global market leader in the design and manufacture of decision support tools for the renewable energy industry, primarily wind. NRG has annualized sales of approximately $45 million and will be included in the Company’s Utilities Solution Group (USG) segment.
OUTLOOK
Excluding the impact of the NRG acquisition announced on May 8, 2017, Management’s current expectations for 2017 remain consistent with the details outlined in the Business Outlook presented in the Company’s November 7, 2016 release.
The partial year contribution from the NRG acquisition to 2017 expected sales and EPS, net of any non-cash purchase accounting charges or inventory step-up, is currently being finalized and is not included in the following guidance. Management will update its 2017 outlook once the balance of the year forecast and related purchase accounting is finalized.
On a quarterly basis, Management continues to expect 2017 revenues and EPS to reflect a profile similar to 2016, including EPS being more second-half weighted. Third quarter 2017 EPS is expected to be in the range of $0.46 to $0.51 per share, excluding the impact of the NRG acquisition. Management expects 2017 EPS to be in the range of $2.16 - $2.26 per share, excluding the impact of the NRG acquisition.
17 |
CRITICAL ACCOUNTING POLICIES
Management has evaluated the accounting policies used in the preparation of the Company’s financial statements and related notes and believes those policies to be reasonable and appropriate. Certain of these accounting policies require the application of significant judgment by Management in selecting appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on historical experience, trends in the industry, information provided by customers and information available from other outside sources, as appropriate. The most significant areas involving Management judgments and estimates may be found in the Critical Accounting Policies section of Management’s Discussion and Analysis and in Note 1 to the Consolidated Financial Statements contained in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2016.
OTHER MATTERS
Contingencies
As a normal incident of the business in which the Company is engaged, various claims, charges and litigation are asserted or commenced against the Company. Additionally, the Company is currently involved in various stages of investigation and remediation relating to environmental matters. In the opinion of Management, the aggregate costs involved in the resolution of these matters, and final judgments, if any, which might be rendered against the Company, are adequately reserved, are covered by insurance, or would not have a material adverse effect on the Company’s results from operations, capital expenditures, or competitive position.
FORWARD LOOKING STATEMENTS
Statements contained in this Form 10-Q regarding future events and the Company’s future results that reflect or are based on current expectations, estimates, forecasts, projections or assumptions about the Company’s performance and the industries in which the Company operates are considered “forward-looking statements” within the meaning of the safe harbor provisions of the Federal securities laws. These include, but are not necessarily limited to, statements about: the amount and timing of future sales, revenues, cash flows, EBIT and EPS; the adequacy of the Company’s credit facility and the Company’s ability to increase it; the outcome of current litigation, claims and charges; continued reinvestment of foreign earnings and U.S. income tax liabilities in the event that foreign earnings were distributed; future income tax liabilities and effective tax rate; timing of the repayment of the current portion of the Company’s long-term debt; changes in the amount of unrecognized tax benefits; the recognition and timing of costs related to share-based compensation arrangements; returns on retirement plan assets; estimates or projections made in connection with the Company’s accounting policies; market risks relating to the Company’s operations and changes in interest rates and the Company’s ability to hedge against or otherwise manage them through the use of derivative financial instruments; and any other statements contained herein which are not strictly historical. Words such as expects, anticipates, targets, goals, projects, intends, plans, believes, estimates, variations of such words, and similar expressions are intended to identify such forward-looking statements.
Investors are cautioned that such statements are only predictions and speak only as of the date of this Form 10-Q, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company’s operations and business environment, including but not limited to those described in Item 1A, “Risk Factors,” of the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2016, and the following: the impacts of natural disasters on the Company’s operations and those of the Company’s customers and suppliers; the timing and content of future contract awards or customer orders; termination for convenience of customer contracts or orders; financial exposure in connection with Company guarantees of certain Aclara contracts; weakening of economic conditions in served markets; the success of the Company’s competitors; changes in customer demands or customer insolvencies; competition; intellectual property rights; technical difficulties; the availability of selected acquisitions; delivery delays or defaults by customers; performance issues with key customers, suppliers and subcontractors; material changes in the costs of certain raw materials; labor disputes; changes in laws and regulations including but not limited to changes in accounting standards and taxation requirements; changes in interest rates; costs relating to environmental matters; litigation uncertainty; and the integration of recently acquired businesses.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market risks relating to the Company’s operations result primarily from changes in interest rates and changes in foreign currency exchange rates. The Company is exposed to market risk related to changes in interest rates and selectively uses derivative financial instruments, including forward contracts and swaps, to manage these risks. During 2016, the Company entered into several forward contracts to purchase pounds sterling to hedge two deferred payments due in connection with the acquisition of Plastique. All derivative instruments are reported on the balance sheet at fair value. The derivative instruments are designated as cash flow hedges and the gain or loss on the respective derivative is deferred in accumulated other comprehensive income until recognized in earnings with the underlying hedged item. There has been no material change to the Company’s market risks since September 30, 2016. See Note 12 to the Consolidated Financial Statements in Item 1 of this Report for a summary of the Company’s outstanding derivative financial instruments as of March 31, 2017. Refer to the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2016 for further discussion about market risk.
18 |
ITEM 4. CONTROLS AND PROCEDURES
The Company carried out an evaluation, under the supervision and with the participation of Management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of that date. Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in Company reports filed or submitted under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. There has been no change in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
19 |
PART II. OTHER INFORMATION
ITEM 6. EXHIBITS
Exhibit Number | ||||
3.1(a) | Restated Articles of Incorporation | Incorporated by reference to Exhibit 3(a) to Form 10-K for the fiscal year ended September 30, 1999 (File No. 1-10596) | ||
3.1(b) | Amended Certificate of Designation, Preferences and Rights of Series A Participating Cumulative Preferred Stock of the Registrant | Incorporated by reference to Exhibit 4(e) to Form 10-Q for the fiscal quarter ended March 31, 2000 (File No. 1-10596) | ||
3.1(c) | Articles of Merger effective July 10, 2000 | Incorporated by reference to Exhibit 3(c) to Form 10-Q for the fiscal quarter ended June 30, 2000 (File No. 1-10596) | ||
3.2 | Bylaws | Incorporated by reference to Exhibit 3 to Form 8-K filed May 7, 2014 (File No. 1-10596) | ||
4.1 | Specimen revised Common Stock Certificate | Incorporated by reference to Exhibit 4.1 to Form 10-Q for the fiscal quarter ended March 31, 2010 (File No. 1-10596) | ||
4.2 | Amended and Restated Credit Agreement dated as of December 21, 2015 among the Registrant, the Foreign Subsidiary Borrowers from time to time party thereto, the Lenders from time to time party thereto, JP Morgan Chase Bank, N.A. as Administrative Agent, and Bank of America, N.A., BMO Harris Bank, N.A., SunTrust Bank and Wells Fargo Bank, National Association as Co-Documentation Agents | Incorporated by reference to Exhibit 4.1 to Form 8-K dated December 23, 2015 (File No. 1-10596) | ||
4.3 | Amendment No. 1 to December 21, 2015 Credit Agreement, effective September 30, 2016 | Incorporated by reference to Exhibit 4.4 to Form 10-K for the fiscal year ended September 30, 2016 (File No. 1-10596) | ||
31.1 | Certification of Chief Executive Officer relating to Form 10-Q for period ended March 31, 2017 | Filed herewith | ||
31.2 | Certification of Chief Financial Officer relating to Form 10-Q for period ended March 31, 2017 | Filed herewith | ||
32 | Certification of Chief Executive Officer and Chief Financial Officer relating to Form 10-Q for period ended March 31, 2017 | Filed herewith | ||
101.INS | XBRL Instance Document* | Submitted herewith | ||
101.SCH | XBRL Schema Document* | Submitted herewith | ||
101.CAL | XBRL Calculation Linkbase Document* | Submitted herewith | ||
101.DEF | XBRL Definition Linkbase Document* | Submitted herewith | ||
101.LAB | XBRL Label Linkbase Document* | Submitted herewith | ||
101.PRE | XBRL Presentation Linkbase Document* | Submitted herewith |
* Exhibit 101 to this report consists of documents formatted in XBRL (Extensible Business Reporting Language). The financial information contained in the XBRL – related documents is “unaudited” or “unreviewed”.
20 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ESCO TECHNOLOGIES INC. | |
/s/ Gary E. Muenster | |
Gary E. Muenster | |
Executive Vice President and Chief Financial Officer | |
(As duly authorized officer and principal accounting and financial officer of the registrant) |
Dated: May 9, 2017
21 |